All Articles on COVID-19 Vaccine
Promising interim results for NIH-Moderna COVID-19 vaccineThe investigational vaccine that KPWHRI’s team first tested shows an efficacy rate of 94.5% as Phase 3 research continues.
The investigational vaccine that KPWHRI’s team first tested shows an efficacy rate of 94.5% as Phase 3 research continues.